Last reviewed · How we verify

Methodological Design for Evaluating the Immune Capacity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19 Human Infection: Intelligent Medicine Integration.

NCT05054075 Phase 2 UNKNOWN

The present work proposes to find if a bio-active composite in the hemolymph or plasma of the freshwater bivalve Anodonta cygnea is able to offer immunity and specificity for meliorating the major symptoms in human SARS and COVID-19 lineage infection. The Methodology concerns in silico procedures using organic fluids from 54 bivalves (in very specific conditions) to evaluate their therapeutic effects in 6 voluntary SARS and COVID-19 infected persons with an integrative diagnosis by a computational Mora®Nova apparatus to access the basal and experimental human physiological parameters.

Details

Lead sponsorUniversidade do Porto
PhasePhase 2
StatusUNKNOWN
Enrolment45
Start date2021-10-01
Completion2022-11

Conditions

Interventions

Primary outcomes

Countries

Portugal